Aarti Industries Ltd
Incorporated in 1984, Aarti Industries Ltd manufactures and deals in Speciality Chemicals and Pharmaceuticals[1]
- Market Cap ₹ 26,247 Cr.
- Current Price ₹ 723
- High / Low ₹ 763 / 438
- Stock P/E 60.5
- Book Value ₹ 139
- Dividend Yield 0.35 %
- ROCE 10.4 %
- ROE 11.6 %
- Face Value ₹ 5.00
Pros
Cons
- Tax rate seems low
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -3.39%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,667 | 2,086 | 2,619 | 2,890 | 3,006 | 3,163 | 3,806 | 4,168 | 4,186 | 4,506 | 6,086 | 6,619 | 6,255 | |
1,417 | 1,725 | 2,217 | 2,424 | 2,434 | 2,509 | 3,106 | 3,202 | 3,209 | 3,525 | 4,365 | 5,530 | 5,310 | |
Operating Profit | 249 | 361 | 402 | 466 | 572 | 654 | 700 | 965 | 977 | 982 | 1,720 | 1,089 | 945 |
OPM % | 15% | 17% | 15% | 16% | 19% | 21% | 18% | 23% | 23% | 22% | 28% | 16% | 15% |
4 | 4 | 11 | 9 | 6 | 2 | 7 | 2 | 9 | 1 | 1 | 1 | 8 | |
Interest | 72 | 95 | 118 | 138 | 117 | 117 | 132 | 183 | 125 | 86 | 102 | 168 | 185 |
Depreciation | 55 | 83 | 89 | 82 | 98 | 123 | 146 | 163 | 185 | 231 | 246 | 310 | 363 |
Profit before tax | 126 | 187 | 206 | 255 | 363 | 416 | 429 | 622 | 676 | 665 | 1,372 | 611 | 405 |
Tax % | 29% | 29% | 26% | 24% | 26% | 21% | 19% | 19% | 19% | 19% | 14% | 11% | |
104 | 135 | 163 | 208 | 268 | 328 | 346 | 504 | 547 | 535 | 1,186 | 545 | 434 | |
EPS in Rs | 3.26 | 4.25 | 4.58 | 5.81 | 7.71 | 9.62 | 10.24 | 14.18 | 15.39 | 15.02 | 32.71 | 15.04 | 11.97 |
Dividend Payout % | 27% | 24% | 25% | 24% | 28% | 3% | 2% | 19% | 11% | 10% | 11% | 17% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 12% |
3 Years: | 17% |
TTM: | -7% |
Compounded Profit Growth | |
---|---|
10 Years: | 15% |
5 Years: | 11% |
3 Years: | 1% |
TTM: | -26% |
Stock Price CAGR | |
---|---|
10 Years: | 38% |
5 Years: | 15% |
3 Years: | 4% |
1 Year: | 33% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 19% |
3 Years: | 19% |
Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 40 | 40 | 44 | 44 | 42 | 41 | 41 | 43 | 87 | 87 | 181 | 181 | 181 |
Reserves | 551 | 717 | 826 | 972 | 1,096 | 1,321 | 1,538 | 2,587 | 2,892 | 3,416 | 4,335 | 4,739 | 4,848 |
628 | 849 | 1,039 | 1,202 | 1,292 | 1,564 | 2,083 | 2,401 | 2,098 | 2,857 | 2,587 | 2,907 | 3,207 | |
442 | 571 | 760 | 719 | 538 | 573 | 730 | 826 | 1,256 | 1,282 | 748 | 754 | 1,012 | |
Total Liabilities | 1,660 | 2,176 | 2,670 | 2,938 | 2,966 | 3,499 | 4,391 | 5,858 | 6,332 | 7,642 | 7,851 | 8,581 | 9,248 |
443 | 674 | 826 | 967 | 1,246 | 1,697 | 1,998 | 2,147 | 2,468 | 3,593 | 3,595 | 4,861 | 5,283 | |
CWIP | 54 | 69 | 117 | 193 | 313 | 270 | 436 | 795 | 1,418 | 1,298 | 1,346 | 1,096 | 1,057 |
Investments | 94 | 95 | 117 | 139 | 41 | 47 | 47 | 33 | 37 | 64 | 28 | 17 | 24 |
1,068 | 1,338 | 1,609 | 1,639 | 1,366 | 1,486 | 1,910 | 2,884 | 2,409 | 2,688 | 2,882 | 2,607 | 2,884 | |
Total Assets | 1,660 | 2,176 | 2,670 | 2,938 | 2,966 | 3,499 | 4,391 | 5,858 | 6,332 | 7,642 | 7,851 | 8,581 | 9,248 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
121 | 230 | 315 | 340 | 574 | 470 | 335 | 736 | 1,102 | 873 | 519 | 1,310 | |
-134 | -229 | -291 | -298 | -452 | -529 | -610 | -797 | -1,124 | -1,322 | -1,169 | -1,330 | |
11 | 1 | -22 | -23 | -128 | 58 | 279 | 833 | -535 | 614 | 412 | 47 | |
Net Cash Flow | -2 | 2 | 2 | 19 | -7 | -0 | 4 | 772 | -557 | 165 | -239 | 27 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 89 | 75 | 62 | 55 | 64 | 61 | 63 | 68 | 66 | 64 | 65 | 52 |
Inventory Days | 108 | 150 | 147 | 123 | 108 | 136 | 144 | 152 | 174 | 190 | 143 | 115 |
Days Payable | 59 | 74 | 90 | 55 | 67 | 71 | 69 | 55 | 72 | 117 | 53 | 45 |
Cash Conversion Cycle | 138 | 152 | 119 | 123 | 105 | 125 | 138 | 165 | 168 | 137 | 155 | 122 |
Working Capital Days | 124 | 120 | 99 | 91 | 96 | 93 | 103 | 99 | 93 | 63 | 120 | 95 |
ROCE % | 17% | 20% | 18% | 19% | 20% | 19% | 16% | 18% | 15% | 13% | 22% | 10% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 2h
- Certificate As Per Regulation 40(9) And 40(10) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2024 2d
- Re-Designation As The Vice-Chairman Of The Company-Shri Renil Rajendra Gogri. 5 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Apr - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 - Quarter ended March 31, 2024
-
Compliance Certificate For Year Ended March 31, 2024
3 Apr - Compliance Certificate pursuant to Regulation 7(3) of SEBI LODR
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT REC
-
Mar 2023TranscriptNotesPPT
-
Mar 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Sep 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Sep 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
May 2021Transcript PPT
-
Jan 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
May 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jul 2019TranscriptNotesPPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Nov 2017TranscriptPPT
-
Aug 2017TranscriptPPT
-
Jun 2017Transcript PPT
-
Mar 2017TranscriptPPT
-
Nov 2016TranscriptPPT
-
Aug 2016TranscriptPPT
-
Jun 2016Transcript PPT
-
Apr 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
-
Feb 2016Transcript PPT
-
Jan 2016TranscriptNotesPPT
Business Overview:[1][2]
Company manufactures speciality chemicals in Benzene based derivatives. Key value chains include Nitro Chloro Benzenes (NCBs), Di-Chloro Benzenes (DCBs), Phenylenediamines (PDAs), Nitro Toluene Value Chain and Equivalent Sulphuric Acid (E.S.A) & downstream.
Company has 21+ manufacturing units, 100+ products, 700+ domestic customers, 400+ export customers in 60+ countries with major presence in the USA, Europe, Japan, etc.